{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "messageBoardId": "finmb_144939852", "regularMarketChangePercent": -0.8978577, "regularMarketPrice": 290.29, "exchange": "NMS", "shortName": "Madrigal Pharmaceuticals, Inc.", "longName": "Madrigal Pharmaceuticals, Inc.", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "firstTradeDateMilliseconds": 1170772200000, "priceHint": 2, "preMarketChange": -3.2900085, "preMarketChangePercent": -1.1333523, "preMarketTime": 1684227996, "preMarketPrice": 287.0, "regularMarketChange": -2.630005, "regularMarketTime": 1684180804, "regularMarketDayHigh": 298.045, "regularMarketDayRange": "289.43 - 298.045", "regularMarketDayLow": 289.43, "regularMarketVolume": 213073, "regularMarketPreviousClose": 292.92, "bid": 0.0, "ask": 0.0, "bidSize": 11, "askSize": 8, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 295.83, "averageDailyVolume3Month": 409323, "averageDailyVolume10Day": 326930, "fiftyTwoWeekLowChange": 233.08002, "fiftyTwoWeekLowChangePercent": 4.0741134, "fiftyTwoWeekRange": "57.21 - 322.67", "fiftyTwoWeekHighChange": -32.380005, "fiftyTwoWeekHighChangePercent": -0.100350216, "fiftyTwoWeekLow": 57.21, "fiftyTwoWeekHigh": 322.67, "dividendDate": 1469404800, "earningsTimestamp": 1683633601, "earningsTimestampStart": 1690979400, "earningsTimestampEnd": 1691411400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -17.07, "epsForward": -14.17, "epsCurrentYear": -19.57, "priceEpsCurrentYear": -14.833419, "sharesOutstanding": 18283100, "bookValue": 8.212, "fiftyDayAverage": 266.8764, "fiftyDayAverageChange": 23.413605, "fiftyDayAverageChangePercent": 0.08773202, "twoHundredDayAverage": 173.01434, "twoHundredDayAverageChange": 117.275665, "twoHundredDayAverageChangePercent": 0.67783785, "marketCap": 5307401216, "forwardPE": -20.486238, "priceToBook": 35.34949, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.8 - Buy", "tradeable": false, "cryptoTradeable": false, "displayName": "Madrigal Pharmaceuticals", "symbol": "MDGL"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Four Tower Bridge", "address2": "Suite 200 200 Barr Harbor Drive", "city": "West Conshohocken", "state": "PA", "zip": "19428", "country": "United States", "phone": "267 824 2827", "website": "https://www.madrigalpharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor beta agonist, which is in Phase III clinical trials for treating NASH. The company is also developing MGL-3745, a backup compound to resmetirom. The company is headquartered in West Conshohocken, Pennsylvania.", "fullTimeEmployees": 92, "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul A. Friedman M.D.", "age": 79, "title": "Chairman & CEO", "yearBorn": 1943, "fiscalYear": 2022, "totalPay": {"raw": 1155485, "fmt": "1.16M", "longFmt": "1,155,485"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 126106624, "fmt": "126.11M", "longFmt": "126,106,624"}}, {"maxAge": 1, "name": "Dr. Rebecca A. Taub M.D.", "age": 70, "title": "Founder, Chief Medical Officer, Pres of R&D and Director", "yearBorn": 1952, "fiscalYear": 2022, "totalPay": {"raw": 939826, "fmt": "939.83k", "longFmt": "939,826"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 75873376, "fmt": "75.87M", "longFmt": "75,873,376"}}, {"maxAge": 1, "name": "Mr. Alex G. Howarth", "age": 53, "title": "Sr. VP & CFO", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 757256, "fmt": "757.26k", "longFmt": "757,256"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 4068969, "fmt": "4.07M", "longFmt": "4,068,969"}}, {"maxAge": 1, "name": "Mr. Brian J. Lynch J.D.", "age": 60, "title": "Sr. VP & Gen. Counsel", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 763749, "fmt": "763.75k", "longFmt": "763,749"}, "exercisedValue": {"raw": 1272390, "fmt": "1.27M", "longFmt": "1,272,390"}, "unexercisedValue": {"raw": 13498566, "fmt": "13.5M", "longFmt": "13,498,566"}}, {"maxAge": 1, "name": "Mr. Remy  Sukhija", "age": 50, "title": "Sr. VP & Chief Commercial Officer", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 785199, "fmt": "785.2k", "longFmt": "785,199"}, "exercisedValue": {"raw": 6399000, "fmt": "6.4M", "longFmt": "6,399,000"}, "unexercisedValue": {"raw": 3538275, "fmt": "3.54M", "longFmt": "3,538,275"}}, {"maxAge": 1, "name": "Dr. Kianoush  Motesharei Ph.d.", "age": 52, "title": "Sr. VP of Bus. & Corp. Devel.", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Edward  Chiang", "title": "Sr. VP of Clinical & Technical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Thomas W. Hare", "title": "Sr. VP of Clinical Management", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Robert E. Waltermire Ph.D.", "age": 58, "title": "Chief Pharmaceutical Devel. Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Stephen  Dodge M.B.A., Pharm.D.", "title": "Sr. VP of Global Medical Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 6, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}